Antigenic conservation of an immunodominant invariable region of the VlsE lipoprotein among European pathogenic genospecies of Borrelia burgdorferi SL.

Lyme disease is caused by genetically divergent spirochetes, including 3 pathogenic genospecies: Borrelia burgdorferi sensu stricto, B. garinii, and B. afzelii. Serodiagnosis is complicated by this genetic diversity. A synthetic peptide (C(6)), based on the 26-mer invariable region (IR(6)) of the variable surface antigen of B. burgdorferi (VlsE), was used as ELISA antigen, to test serum samples collected from mice experimentally infected with the 3 genospecies and from European patients with Lyme disease. Regardless of the infecting strains, mice produced a strong antibody response to C(6), which indicates that IR(6) is antigenically conserved among the pathogenic genospecies. Twenty of 23 patients with culture-confirmed erythema migrans had a detectable antibody response to C(6). A sensitivity of 95.2% was achieved, with serum samples collected from patients with well-defined acrodermatitis chronica atrophicans. Fourteen of 20 patients with symptoms of late Lyme disease also had a positive anti-IR(6) ELISA. Thus, it is possible that C(6) may be used to serodiagnose Lyme disease universally.

[1]  D. Roberts,et al.  The bdr gene families of the Lyme disease and relapsing fever spirochetes: potential influence on biology, pathogenesis, and evolution. , 2000, Emerging infectious diseases.

[2]  T. Schwan,et al.  Temporal Changes in Outer Surface Proteins A and C of the Lyme Disease-Associated Spirochete, Borrelia burgdorferi, during the Chain of Infection in Ticks and Mice , 2000, Journal of Clinical Microbiology.

[3]  A. Steere,et al.  Sensitive and Specific Serodiagnosis of Lyme Disease by Enzyme-Linked Immunosorbent Assay with a Peptide Based on an Immunodominant Conserved Region of Borrelia burgdorferi VlsE , 1999, Journal of Clinical Microbiology.

[4]  Y. Gu,et al.  An immunodominant conserved region within the variable domain of VlsE, the variable surface antigen of Borrelia burgdorferi. , 1999, Journal of immunology.

[5]  Ira Schwartz,et al.  Molecular Typing of Borrelia burgdorferiSensu Lato: Taxonomic, Epidemiological, and Clinical Implications , 1999, Clinical Microbiology Reviews.

[6]  A. E. van den Bogaard,et al.  Evaluation of Fifteen Commercially Available Serological Tests for Diagnosis of Lyme Borreliosis , 1999, European Journal of Clinical Microbiology and Infectious Diseases.

[7]  R. Nadelman,et al.  Lyme disease serology: problems and opportunities. , 1999, JAMA.

[8]  Langone Jj,et al.  Role of serology in the diagnosis of Lyme disease. , 1999 .

[9]  B. Wilske,et al.  Validity of Interpretation Criteria for Standardized Western Blots (Immunoblots) for Serodiagnosis of Lyme Borreliosis Based on Sera Collected throughout Europe , 1999, Journal of Clinical Microbiology.

[10]  S. Batsford,et al.  Analysis of antibody response to the outer surface protein family in lyme borreliosis patients. , 1998, The Journal of infectious diseases.

[11]  G. Stanek,et al.  Detection of Borrelia burgdorferi sensu lato in ticks: immunofluorescence assay versus polymerase chain reaction. , 1998, Zentralblatt fur Bakteriologie : international journal of medical microbiology.

[12]  V. Fingerle,et al.  Impact of Strain Heterogeneity on Lyme Disease Serology in Europe: Comparison of Enzyme-Linked Immunosorbent Assays Using Different Species of Borrelia burgdorferi Sensu Lato , 1998, Journal of Clinical Microbiology.

[13]  Y. Lobet,et al.  Immunization with a polyvalent OspA vaccine protects mice against Ixodes ricinus tick bites infected by Borrelia burgdorferi ss, Borrelia garinii and Borrelia afzelii. , 1997, Vaccine.

[14]  B. Wilske,et al.  Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato , 1997, Journal of Clinical Microbiology.

[15]  S. Norris,et al.  Antigenic Variation in Lyme Disease Borreliae by Promiscuous Recombination of VMP-like Sequence Cassettes , 1997, Cell.

[16]  L. Bakken,et al.  Interlaboratory comparison of test results for detection of Lyme disease by 516 participants in the Wisconsin State Laboratory of Hygiene/College of American Pathologists Proficiency Testing Program , 1997, Journal of clinical microbiology.

[17]  K. Wan,et al.  [Studies on epidemiology and etiology of Lyme disease in China]. , 1997, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[18]  S. Cutler.  Laboratory diagnosis of Lyme borreilosis is under review , 1996, The Lancet.

[19]  Ruth R. Montgomery,et al.  Direct demonstration of antigenic substitution of Borrelia burgdorferi ex vivo: exploration of the paradox of the early immune response to outer surface proteins A and C in Lyme disease , 1996, The Journal of experimental medicine.

[20]  M. Cinco,et al.  Prevalence of IgG reactivity in Lyme borreliosis patients versus Borrelia garinii and Borrelia afzelii in a restricted area of Northern Italy. , 1995, FEMS immunology and medical microbiology.

[21]  A. Lindberg,et al.  An epidemiologic study of Lyme disease in southern Sweden. , 1995, The New England journal of medicine.

[22]  T. Schwan,et al.  Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[23]  G. Baranton,et al.  Diversity of Borrelia burgdorferi sensu lato evidenced by restriction fragment length polymorphism of rrf (5S)-rrl (23S) intergenic spacer amplicons. , 1994, International journal of systematic bacteriology.

[24]  A. Steere,et al.  Antibody responses to the three genomic groups of Borrelia burgdorferi in European Lyme borreliosis. , 1994, The Journal of infectious diseases.

[25]  U. Schaible,et al.  Mode of inoculation of the Lyme disease agent Borrelia burgdorferi influences infection and immune responses in inbred strains of mice. , 1993, The Journal of infectious diseases.

[26]  J. Roehrig,et al.  The hamster immune response to tick-transmitted Borrelia burgdorferi differs from the response to needle-inoculated, cultured organisms. , 1992, Journal of immunology.

[27]  C. Vigo‐Pelfrey,et al.  Serodiagnosis of Lyme borreliosis by western immunoblot: reactivity of various significant antibodies against Borrelia burgdorferi , 1992, Journal of clinical microbiology.

[28]  Jean Côté,et al.  Lyme Disease , 1991, International journal of dermatology.

[29]  B. Luft,et al.  Immunologic and structural characterization of the dominant 66- to 73-kDa antigens of Borrelia burgdorferi. , 1991, Journal of immunology.

[30]  S. M. van der Linden,et al.  The prevalence and incidence of clinical and asymptomatic Lyme borreliosis in a population at risk. , 1991, The Journal of infectious diseases.

[31]  B. Rehse-Küpper,et al.  Chronic Neurologic Manifestations of Erythema Migrans Borreliosis , 1988, Annals of the New York Academy of Sciences.

[32]  A. Hovmark,et al.  Early and Late Cutaneous Manifestations in Ixodes‐borne Borreliosis (Erythema Migrans Borreliosis, Lyme Borreliosis) a , 1988, Annals of the New York Academy of Sciences.

[33]  N. Pedersen,et al.  Immunochemical characterization of and isolation of the gene for a Borrelia burgdorferi immunodominant 60-kilodalton antigen common to a wide range of bacteria , 1988, Infection and immunity.

[34]  F. Strle,et al.  LYME DISEASE IN EUROPE , 1987, The Lancet.

[35]  A. Barbour,et al.  A Borrelia-specific monoclonal antibody binds to a flagellar epitope , 1986, Infection and immunity.

[36]  B. Wilske,et al.  European erythema migrans disease and related disorders. , 1984, The Yale journal of biology and medicine.

[37]  A. Steere,et al.  The early clinical manifestations of Lyme disease. , 1983, Annals of internal medicine.

[38]  R. Ackermann,et al.  Tick-borne meningopolyneuritis (Garin-Bujadoux, Bannwarth). , 1976, The Yale journal of biology and medicine.

[39]  J. J. Langone,et al.  Role of serology in the diagnosis of Lyme disease. , 1999, JAMA.

[40]  Lyme disease -- United States, 1996. , 1997, MMWR. Morbidity and mortality weekly report.

[41]  U. Wurster,et al.  Chronic neurologic manifestations of Lyme disease. , 1991, The New England journal of medicine.

[42]  A. Steere.  Medical progress. Lyme disease , 1989 .